Mir140-KO Mouse
一般名
Mir140-KO
製品ID
S-KO-09929
背景情報
C57BL/6JCya
系統ID
KOCMP-387158-Mir140-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Mir140-KO Mouse(カタログ番号S-KO-09929)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Mir140-KO
系統ID
KOCMP-387158-Mir140-B6J-VA
遺伝子名
製品ID
S-KO-09929
遺伝子別名
Mirn140, mir-140, mmu-mir-140
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 8
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000083505
NCBIトランスクリプトID
NR_029553
ターゲット領域
Exon 1
有効領域の大きさ
~1.5 kb
遺伝子研究の概要
MicroRNA-140 (miR-140) is a critical non-coding RNA molecule that plays a pivotal role in various biological processes, particularly in skeletal development and cartilage maintenance. miR-140 is specifically expressed in chondrocytes, the cells responsible for cartilage formation and maintenance, and its expression is essential for normal skeletal development. Dysregulation of miR-140 has been linked to skeletal dysplasias, such as those caused by mutations in miR-140 and miR-17~92 miRNAs [5]. These dysplasias highlight the importance of miR-140 in regulating gene expression and maintaining the structural integrity of the skeleton.
In addition to its role in skeletal development, miR-140 has been implicated in the pathogenesis of osteoarthritis (OA), a chronic musculoskeletal disorder characterized by the degeneration of joint cartilage and the underlying bone. Studies have shown that miR-140 is involved in the regulation of chondrocyte function, including proliferation, migration, apoptosis, and extracellular matrix (ECM) secretion. For example, exosomes derived from human urine-derived stem cells (hUSCs) overexpressing miR-140-5p have been shown to alleviate knee OA by downregulating vascular endothelial growth factor A (VEGFA), a key factor in OA progression [3]. Moreover, the delivery of miR-140 to chondrocytes using engineered exosomes has been demonstrated to enhance cartilage regeneration and subchondral bone remodeling in a rat OA model, further highlighting its therapeutic potential [6].
miR-140 is also involved in the regulation of cell fate and differentiation. In obesity, miR-140 has been shown to promote adipogenesis and contribute to bone deterioration by targeting the Pparα-Abca1 axis in skeletal stem/progenitor cells (SSPCs) [2]. This finding suggests that miR-140 may play a role in the pathogenesis of obesity-related bone disorders by influencing the differentiation of SSPCs.
Furthermore, miR-140 has been implicated in the regulation of inflammation and immune responses. For example, downregulation of miR-140 has been associated with cancer cell survival and escape from stresses, highlighting its potential role in tumor progression [1]. Additionally, miR-140 has been shown to regulate the immune response in rheumatoid arthritis (RA) and OA, further underscoring its importance in immune-related diseases [4].
Overall, miR-140 is a crucial regulator of skeletal development, cartilage maintenance, and immune responses. Its dysregulation has been linked to various diseases, including skeletal dysplasias, OA, and cancer. Further research is needed to fully understand the mechanisms by which miR-140 functions and its potential therapeutic applications in the treatment of these diseases.
References:
1. Ginckels, Pieterjan, Holvoet, Paul. 2022. Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs. In The Yale journal of biology and medicine, 95, 129-152. doi:. https://pubmed.ncbi.nlm.nih.gov/35370493/
2. He, Chen, Hu, Chen, He, Wen-Zhen, Lei, Guang-Hua, Li, Chang-Jun. 2024. Macrophage-derived extracellular vesicles regulate skeletal stem/progenitor Cell lineage fate and bone deterioration in obesity. In Bioactive materials, 36, 508-523. doi:10.1016/j.bioactmat.2024.06.035. https://pubmed.ncbi.nlm.nih.gov/39072285/
3. Liu, Yuan, Zeng, Yi, Si, Hai-Bo, Xie, Hui-Qi, Shen, Bin. 2022. Exosomes Derived From Human Urine-Derived Stem Cells Overexpressing miR-140-5p Alleviate Knee Osteoarthritis Through Downregulation of VEGFA in a Rat Model. In The American journal of sports medicine, 50, 1088-1105. doi:10.1177/03635465221073991. https://pubmed.ncbi.nlm.nih.gov/35179989/
4. Tanaka-Watanabe, Yoko, Asahara, Hiroshi. . [Joint and microRNA]. In Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 35, 447-54. doi:. https://pubmed.ncbi.nlm.nih.gov/23291479/
5. Shvedova, Maria, Kobayashi, Tatsuya. 2020. MicroRNAs in cartilage development and dysplasia. In Bone, 140, 115564. doi:10.1016/j.bone.2020.115564. https://pubmed.ncbi.nlm.nih.gov/32745689/
6. Liang, Yujie, Xu, Xiao, Li, Xingfu, Wang, Daping, Xia, Jiang. 2020. Chondrocyte-Targeted MicroRNA Delivery by Engineered Exosomes toward a Cell-Free Osteoarthritis Therapy. In ACS applied materials & interfaces, 12, 36938-36947. doi:10.1021/acsami.0c10458. https://pubmed.ncbi.nlm.nih.gov/32814390/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
